RPS6KB1 and cancer: Considering the inhibitory role of C2-ceramide in the AKT pathway and the activation of Csk, C2-ceramide could serve as an effective anti-cancer drug with potential to inhibit the PI3K/AKT/mTOR/p70S6K axis as an Src inhibitor, which is harmful to cell survival.